--23andMe said it would disable an application-programming interface that provided anonymized raw genomic data to app developers, CNBC reported.

--In an email to developers, 23andMe said "we're updating our API program to focus on apps that build on the interpretations and results we provide to our customers," CNBC reported. 23andMe considered opening an app store years ago but didn't proceed because of challenges in vetting app developers, CNBC reported.

--In July, GlaxoSmithKline PLC (GSK) said it would invest $300 million in 23andMe.

https://www.cnbc.com/2018/08/23/23andme-is-telling-developers-that-it-plans-to-shut-off-its-api-in-two-weeks.html

Write to copydesk@wsj.com

(END) Dow Jones Newswires

August 24, 2018 14:12 ET (18:12 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.
GSK (NYSE:GSK)
Historical Stock Chart
From Jul 2024 to Aug 2024 Click Here for more GSK Charts.
GSK (NYSE:GSK)
Historical Stock Chart
From Aug 2023 to Aug 2024 Click Here for more GSK Charts.